AI assistant
DAVITA INC. — Director's Dealing 2015
Jan 6, 2015
30643_dirs_2015-01-06_2a46161c-4141-4ae1-9fd5-9c91cfcad3a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-01-02
Reporting Person: STAFFIERI MICHAEL DAVID (COO, Kidney Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-02 | Common Stock | M | 17000 | $31.70 | Acquired | 17000 | Direct |
| 2015-01-02 | Common Stock | F | 7116 | $75.74 | Disposed | 9884 | Direct |
| 2015-01-02 | Common Stock | S | 9884 | $75.5242 | Disposed | 0 | Direct |
| 2015-01-02 | Common Stock | M | 80000 | $34.515 | Acquired | 80000 | Direct |
| 2015-01-02 | Common Stock | F | 36457 | $75.74 | Disposed | 43543 | Direct |
| 2015-01-02 | Common Stock | S | 43543 | $75.8282 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-02 | Stock Appreciation Rights | $31.70 | M | 17000 | Disposed | 2015-03-31 | Common Stock (17000) | Direct |
| 2015-01-02 | Stock Appreciation Rights | $34.515 | M | 80000 | Disposed | 2015-09-30 | Common Stock (80000) | Direct |
Footnotes
F1: The sales reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014.
F2: Represents the weighted average sale price of $75.5242. The range of prices for the sale of these shares was $75.47 - $75.60, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3: Represents the weighted average sale price of $75.8282. The range of prices for the sale of these shares was $75.60 - $76.31, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F4: Stock Appreciation Rights, granted on 3/31/10, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 33.3% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.
F5: Stock Appreciation Rights, granted on 9/30/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.